Evidence map›Paper›PMID 39172510›Full record

ArticleAngewandte Chemie (International ed. in English)2024

π-Extended 4,5-Fused Bis-Fluorene: Highly Open-Shell Compounds and their Cationic Tetrathiafulvalene Derivatives.

Frédéric Lirette, Viktor Bliksted Roug Pedersen, Félix Gagnon, Mogens Brøndsted Nielsen, Israel Fernández, Jean-François Morin

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Frédéric LiretteDepartment of Chemistry and Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, 1045 Ave de la Medecine, Québec, QC Canada, G1V0A6.
Viktor Bliksted Roug PedersenDepartment of Chemistry, University of Copenhagen, Universitetsparken 5, DK-2100, Copenhagen Ø, Denmark.ORCID https://orcid.org/0000-0003-0661-6351
Félix GagnonDepartment of Chemistry and Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, 1045 Ave de la Medecine, Québec, QC Canada, G1V0A6.
Mogens Brøndsted NielsenDepartment of Chemistry, University of Copenhagen, Universitetsparken 5, DK-2100, Copenhagen Ø, Denmark.ORCID https://orcid.org/0000-0001-8377-0788
Israel FernándezDepartamento de Química Orgánica and Centro de Innovación en Química Avanzada (ORFEO-CINQA), Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040-, Madrid, Spain.ORCID https://orcid.org/0000-0002-0186-9774
Jean-François MorinDepartment of Chemistry and Centre de Recherche sur les Matériaux Avancés (CERMA), Université Laval, 1045 Ave de la Medecine, Québec, QC Canada, G1V0A6.ORCID https://orcid.org/0000-0002-9259-9051

Funding

Natural Sciences and Engineering Research Council of Canada Discovery Grant
6 · The paper itself

Abstract

The synthesis of diradical organic compounds has garnered significant attention due to their thermally accessible spin inversion and optoelectronic properties. Yet, preparing such stable structures with high open-shell behavior remains challenging. Herein, we report the synthesis and properties of four π-extended, fused fluorene derivatives with high diradical character, taking advantage of a molecular design where the closed-shell does not include any Clar sextet, comparatively to a maximum of 5 in the corresponding open-shell state. This led to an unusual open-shell triplet ground state with an outstanding singlet-triplet energy difference (ΔE

Indexed as

AromaticityConjugated moleculesDiradicalExtended fluoreneOpen-shell compounds

Identifiers

PMID39172510
PMCPMC11586689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.